vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and ACME UNITED CORP (ACU). Click either name above to swap in a different company.
ACME UNITED CORP is the larger business by last-quarter revenue ($52.3M vs $44.9M, roughly 1.2× AbCellera Biologics Inc.). ACME UNITED CORP runs the higher net margin — 1.9% vs -19.9%, a 21.8% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 13.8%). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs -2.9%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Acme United Corporation is a supplier of cutting, measuring and safety products for the school, home, office, hardware and industrial markets. The company was organized as a partnership in 1867 and incorporated in 1873 under the laws of the State of Connecticut. It is publicly traded on the NYSE American with symbol ACU.
ABCL vs ACU — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $52.3M |
| Net Profit | $-8.9M | $985.0K |
| Gross Margin | — | 39.7% |
| Operating Margin | -63.7% | 3.3% |
| Net Margin | -19.9% | 1.9% |
| Revenue YoY | 788.4% | 13.8% |
| Net Profit YoY | 73.9% | -40.4% |
| EPS (diluted) | $-0.03 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $52.3M | ||
| Q4 25 | $44.9M | $47.5M | ||
| Q3 25 | $9.0M | $49.1M | ||
| Q2 25 | $17.1M | $54.0M | ||
| Q1 25 | $4.2M | $46.0M | ||
| Q4 24 | $5.0M | $45.9M | ||
| Q3 24 | $6.5M | $48.2M | ||
| Q2 24 | $7.3M | $55.4M |
| Q1 26 | — | $985.0K | ||
| Q4 25 | $-8.9M | $1.9M | ||
| Q3 25 | $-57.1M | $1.9M | ||
| Q2 25 | $-34.7M | $4.8M | ||
| Q1 25 | $-45.6M | $1.7M | ||
| Q4 24 | — | $1.7M | ||
| Q3 24 | $-51.1M | $2.2M | ||
| Q2 24 | $-36.9M | $4.5M |
| Q1 26 | — | 39.7% | ||
| Q4 25 | — | 38.2% | ||
| Q3 25 | — | 39.1% | ||
| Q2 25 | — | 41.0% | ||
| Q1 25 | — | 39.0% | ||
| Q4 24 | — | 38.7% | ||
| Q3 24 | — | 38.5% | ||
| Q2 24 | — | 40.8% |
| Q1 26 | — | 3.3% | ||
| Q4 25 | -63.7% | 6.1% | ||
| Q3 25 | -851.8% | 6.1% | ||
| Q2 25 | -290.2% | 11.8% | ||
| Q1 25 | -1479.6% | 5.3% | ||
| Q4 24 | — | 5.0% | ||
| Q3 24 | -1439.4% | 6.1% | ||
| Q2 24 | -1276.2% | 11.5% |
| Q1 26 | — | 1.9% | ||
| Q4 25 | -19.9% | 3.9% | ||
| Q3 25 | -637.8% | 3.9% | ||
| Q2 25 | -203.3% | 8.8% | ||
| Q1 25 | -1077.2% | 3.6% | ||
| Q4 24 | — | 3.7% | ||
| Q3 24 | -785.4% | 4.6% | ||
| Q2 24 | -504.3% | 8.0% |
| Q1 26 | — | $0.24 | ||
| Q4 25 | $-0.03 | $0.46 | ||
| Q3 25 | $-0.19 | $0.46 | ||
| Q2 25 | $-0.12 | $1.16 | ||
| Q1 25 | $-0.15 | $0.41 | ||
| Q4 24 | — | $0.43 | ||
| Q3 24 | $-0.17 | $0.54 | ||
| Q2 24 | $-0.13 | $1.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $4.2M |
| Total DebtLower is stronger | — | $33.0M |
| Stockholders' EquityBook value | $966.9M | $116.7M |
| Total Assets | $1.4B | $195.2M |
| Debt / EquityLower = less leverage | — | 0.28× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $4.2M | ||
| Q4 25 | $128.5M | $3.6M | ||
| Q3 25 | $83.2M | $5.1M | ||
| Q2 25 | $92.4M | $3.6M | ||
| Q1 25 | $159.3M | $3.4M | ||
| Q4 24 | $156.3M | $6.4M | ||
| Q3 24 | $126.6M | $5.7M | ||
| Q2 24 | $148.3M | $3.8M |
| Q1 26 | — | $33.0M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $116.7M | ||
| Q4 25 | $966.9M | $117.6M | ||
| Q3 25 | $964.0M | $115.8M | ||
| Q2 25 | $1.0B | $113.7M | ||
| Q1 25 | $1.0B | $108.3M | ||
| Q4 24 | $1.1B | $107.0M | ||
| Q3 24 | $1.1B | $106.3M | ||
| Q2 24 | $1.1B | $104.0M |
| Q1 26 | — | $195.2M | ||
| Q4 25 | $1.4B | $171.0M | ||
| Q3 25 | $1.4B | $173.0M | ||
| Q2 25 | $1.4B | $170.9M | ||
| Q1 25 | $1.3B | $163.0M | ||
| Q4 24 | $1.4B | $162.2M | ||
| Q3 24 | $1.4B | $165.5M | ||
| Q2 24 | $1.4B | $173.5M |
| Q1 26 | — | 0.28× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | — |
| Free Cash FlowOCF − Capex | $-44.6M | — |
| FCF MarginFCF / Revenue | -99.4% | — |
| Capex IntensityCapex / Revenue | 21.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-34.7M | $8.2M | ||
| Q3 25 | $-52.6M | $7.1M | ||
| Q2 25 | $-32.4M | $6.3M | ||
| Q1 25 | $-11.6M | $-3.3M | ||
| Q4 24 | $-108.6M | $6.4M | ||
| Q3 24 | $-28.9M | $8.9M | ||
| Q2 24 | $-30.0M | $6.9M |
| Q1 26 | — | — | ||
| Q4 25 | $-44.6M | $7.3M | ||
| Q3 25 | $-61.5M | $301.0K | ||
| Q2 25 | $-45.8M | $4.7M | ||
| Q1 25 | $-22.2M | $-4.7M | ||
| Q4 24 | $-187.0M | $4.7M | ||
| Q3 24 | $-47.4M | $7.5M | ||
| Q2 24 | $-50.1M | $4.4M |
| Q1 26 | — | — | ||
| Q4 25 | -99.4% | 15.3% | ||
| Q3 25 | -687.0% | 0.6% | ||
| Q2 25 | -267.9% | 8.7% | ||
| Q1 25 | -524.0% | -10.2% | ||
| Q4 24 | -3702.8% | 10.2% | ||
| Q3 24 | -728.4% | 15.6% | ||
| Q2 24 | -683.8% | 8.0% |
| Q1 26 | — | — | ||
| Q4 25 | 21.9% | 1.9% | ||
| Q3 25 | 99.7% | 13.8% | ||
| Q2 25 | 78.2% | 3.0% | ||
| Q1 25 | 251.1% | 2.9% | ||
| Q4 24 | 1552.7% | 3.7% | ||
| Q3 24 | 284.6% | 2.8% | ||
| Q2 24 | 274.6% | 4.5% |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.34× | ||
| Q3 25 | — | 3.72× | ||
| Q2 25 | — | 1.33× | ||
| Q1 25 | — | -2.02× | ||
| Q4 24 | — | 3.73× | ||
| Q3 24 | — | 3.99× | ||
| Q2 24 | — | 1.55× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
